PRILOCAINE Drug Patent Profile
✉ Email this page to a colleague
When do Prilocaine patents expire, and what generic alternatives are available?
Prilocaine is a drug marketed by Septodont Inc and is included in two NDAs.
The generic ingredient in PRILOCAINE is epinephrine bitartrate; prilocaine hydrochloride. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the epinephrine bitartrate; prilocaine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PRILOCAINE?
- What are the global sales for PRILOCAINE?
- What is Average Wholesale Price for PRILOCAINE?
Summary for PRILOCAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | PRILOCAINE at DailyMed |
US Patents and Regulatory Information for PRILOCAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septodont Inc | PRILOCAINE HYDROCHLORIDE | prilocaine hydrochloride | INJECTABLE;INJECTION | 079235-001 | Sep 29, 2010 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Septodont Inc | PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | epinephrine bitartrate; prilocaine hydrochloride | INJECTABLE;INJECTION | 078959-001 | Aug 30, 2011 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
